NCT00002542 2020-04-01
Tamoxifen in Treating Women With High-Risk Breast Cancer
Canadian Cancer Trials Group
Phase 3 Completed
Clinical Trials
10 trialsNCT00003577 2013-12-19
Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003893 2013-12-19
Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002579 2013-11-06
Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002755 2013-11-06
Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003012 2013-11-06
Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003680 2013-11-06
Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00003013 2013-09-17
Chemotherapy Plus Surgery in Treating Women With Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002696 2013-08-02
Combination Chemotherapy in Treating Women With Stage III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Suspended
NCT00002784 2013-04-04
15-95
ETOP IBCSG Partners Foundation
Phase 3 Completed